United States Últimas notícias

Apple (NASDAQ:AAPL) faces potential additional patent damages after Taction Technology requested interest and compensation beyond a September jury verdict exceeding $5.7 billion.

Thoma Bravo-backed Proofpoint agreed to buy Varonis in a deal valued at about $6.3 billion. The companies say combining email, collaboration, and data security could create a broader cybersecurity platform, just as AI agents and rising customer demand accelerate industry consolidation. Thoma Bravo Managing Partner Seth Boro joined Bloomberg Open Interest to talk about the deal.

Silgan is teaming up with American Industrial Partners to acquire Trivium Packaging in a deal valued at about $3.4 billion dollars.  Silgan President and CEO Adam J. Greenlee discusses the strategic fit, expected benefits for shareholders and what the deal says about consumer demand and the broader economy.

Tensions between Washington and Kyiv are rising as Ukraine President Volodymyr Zelenskyy accuses the Trump administration of pressuring Ukraine while easing its stance toward Moscow. Leslie Vinjamuri of the Chicago Council on Global Affairs discusses the stakes for Ukraine, Europe, and Republicans heading into the midterms and how the Iran war is affecting US politics.

Copper has surged amid tariff fears, but the rally may be vulnerable if U.S. trade measures don't materialize. Invesco's Kathy Kriskey joins Blooomberg Open Interest to explain how stockpiling, tariff uncertainty, and growing demand from data centers and electrification could shape what happens next.

Bloomberg Intelligence's Mandeep Singh says this week's tech earnings could shift a recent market rebound, amid crosscurrents including concerns about financing and volatility in cloud businesses. He speaks on "Bloomberg Open Interest."

Aditya Bhave, BofA Securities senior US economist, says the Federal Reserve could raise interest rates at its October meeting, challenging the market's strong expectation that policymakers will hold. Bhave speaks about what he's looking for from Federal Reserve Chair Kevin Warsh on "Bloomberg Surveillance."

United Therapeutics (NASDAQ:UTHR) received FDA clearance to proceed with a Phase 2 trial of treprostinil SMI for pulmonary hypertension associated with COPD.

Cullinan Therapeutics (NASDAQ:CGEM) and Taiho Oncology reported a 30.2% intracranial response rate for zipalertinib in 43 evaluable lung cancer patients with brain metastases.

A rally in giant chipmakers buoyed the stock market as dip buyers emerged on bets the artificial-intelligence investment boom will continue to support solid earnings. Nimrit Kang, CIO at North Star Asset Management, discusses a growth scare amid an earnings-driven rally.

At first glance, the past week's inflation data look hot enough to change the Fed debate, but the details were less alarming: Inflation breadth narrowed, and traders expect PCE inflation later this month to tell a similar story. Jennifer Lee, Senior Economist at BMO Capital Markets, discusses global tightening and her outlook for the Fed's inflation fight.

Summit Therapeutics (NASDAQ:SMMT) announced the opening of a Phase 2 kidney cancer trial evaluating ivonescimab-based treatments in approximately 100 patients across two countries.